Barchart.com
[[ type === 'moc' ? 'MARKET ON CLOSE' : 'FREE WEBINAR' ]]
[[ timeLabel ]] WATCH LIVE:
Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Menu
Stocks | Futures | Watchlist | News | More
 
or
Watchlist Watchlist | Portfolio Portfolio | Dashboard Dashboard
Hi,
Site News
Contact
Market:
Your Free 7-Day Premier trial ends on . Extend Your Trial For Another 30 Days. Time remaining
Faster, Cleaner, Better.

First Wave Biopharma Inc (FWBI)

First Wave Biopharma Inc (FWBI)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
News & Headlines for [[ item.sessionDateDisplayLong ]]
Help
Go To:
First Wave BioPharma (NASDAQ: FWBI) Makes Significant Progress in Phase 2 SPAN Clinical Trial Spotlight Growth - Tue Jun 13, 2023

Trial Enrollment Completed for Investigational Therapy of Exocrine Pancreatic Insufficiency First Wave BioPharma, Inc. (NASDAQ: FWBI), a clinical-stage biopharmaceutical company

FWBI : 2.96 (+4.59%)
Wall Street - shutterstock_1321462400
Pre-Market Brief: Stocks Mostly Lower Amid Renewed Recession Fears, Weak China GDP Weighs Barchart - Tue Jan 17, 2023

March S&P 500 futures (ESH23) are trending down -0.33% this morning after three major U.S. benchmark indices shook off early losses and closed higher on Friday as investors assessed the start of the U.S....

MARA : 10.23 (-5.01%)
SIDU : 2.12 (-2.30%)
C : 132.54 (+0.70%)
BAC : 61.99 (+0.08%)
CFG : 68.16 (-1.03%)
JPM : 354.95 (-0.30%)
MS : 211.04 (-1.07%)
ESH23 : 3,957.05s (-0.09%)
BAND : 50.79 (+4.87%)
GS : 1,002.56 (-2.28%)
SNAP : 5.35 (-3.60%)
AN : 204.08 (+1.41%)
ZyVersa Therapeutics Appoints Three New Board Members PR Newswire - Thu Jan 5, 2023

/PRNewswire/ -- ZyVersa Therapeutics, Inc. (Nasdaq: ZVSA, or "ZyVersa"), a clinical- stage specialty biopharmaceutical company developing first-in-class drugs...

ZVSA : 0.0990 (unch)
FWBI : 2.96 (+4.59%)
New to The Street Announces 8 Interviews for This Week’s TV Broadcast, Episode #290, on NEWSMAX January 16, 2022, 10-11 AM ET ACCESS Newswire - Fri Jan 14, 2022

NEW YORK, NY / ACCESSWIRE / January 14, 2022 / FMW Media's New to The Street / Newsmax TV announces the broadcasting line-up of its national syndicated 1- hour TV show this Sunday, January 16, 2022, airing...

SFOR : 0.0205 (+2.50%)
SWISF : 0.0285 (+3.64%)
STX : 816.64 (-1.42%)
GDT : 35.46 (-2.18%)
FWBI : 2.96 (+4.59%)
PHBI : 0.0005 (-44.44%)
SFOR.LN : 48.600 (-1.92%)
SWIS.CN : 0.300 (-6.25%)

Barchart Exclusives

Okta Stock Has More Than Doubled in 2026. AI Agents Could Drive the Next Leg Higher. Barchart - 1 hour ago
Okta is expanding beyond traditional identity security as companies deploy more AI agents that require authentication, permissions and ongoing security controls. Read more
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.